Asek Nelson Makia, M.D.
NPI 1083615033ActiveIndividual· Allergy & Immunology, Allergy· Mitchellville, MD
Allergy & Immunology, Allergy (M.D.) in Mitchellville, Maryland, licensed in MD and DC, with an NPI issued in August 2005. Their prescriptions cost Medicare Part D more than their services did: $333,650 for 1,330 claims, against $95,832 paid for services in 2024. Glaxosmithkline, LLC. was the largest of 16 companies reporting payments in 2025, $3,045 in all, mostly food and beverage.
Overview
| NPI | 1083615033 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Aug 2, 2005 |
| Last updated in NPPES | Mar 4, 2020 |
| Certified by provider | Mar 4, 2020 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Allergy & Immunology, Allergy Primary | 207KA0200X | D0032003 | MD |
| Allergy & Immunology, Allergy | 207KA0200X | MD16084 | DC |
| Pediatrics | 208000000X | D0032003 | MD |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Allergy/Immunology (DC) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 162 |
|---|---|
| Services billed | 6,984 across 23 procedure codes |
| Paid by Medicare | $95,832 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,330 · 1,806 30-day fills |
|---|---|
| Patients | 196 |
| Total drug cost | $333,650 |
| Generic share | 77% of claims |
Education and affiliations
| Graduation year | 1983 |
|---|---|
| Medicare specialty | Allergy/Immunology |
Industry payments (Open Payments)
- 2025$3,045 · 117 payments from 16 companies
- 2024$2,386 · 100 payments from 14 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Glaxosmithkline, LLC. | $711.21 | 31 |
| Astrazeneca Pharmaceuticals LP | $594.06 | 24 |
| Genzyme Corporation | $586.44 | 18 |
| Regeneron Healthcare Solutions, Inc. | $190.65 | 6 |
| Novartis Pharmaceuticals Corporation | $182.54 | 7 |
What the 2025 payments were for
- Food and Beverage$3,020 · 116 payments
- Education$25.00 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records